TDAC

Translational Development Acquisition Corp.NASDAQFinancial Services

$10.56-0.19%ClosedMarket Cap: $231.3M

As of 2026-04-06

Valuation

P/E (TTM)

36.36

PEG

0.00

P/B

-27.95

P/S

0.00

EV/EBITDA

-245.82

DCF Value

—

FCF Yield

2.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

5.0%

ROA

3.5%

ROIC

-0.5%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$-553.3K	4.2%	$-162.3K	$1.6M	$-0.15	—
FY 2025	$0.00	NaN%	$-944.5K	$6.4M	$0.37	—
Q3 2025	$137.7K	-48.8%	$-213.7K	$1.7M	$0.08	—
Q2 2025	$191.8K	15.1%	$-221.1K	$1.6M	$0.07	—
Q1 2025	$223.8K	27.4%	$-347.4K	$1.5M	$0.37	—
Q4 2024	$0.00	NaN%	$-133.4K	$-8.0K	$-0.00	—
FY 2024	$1.1M	69.9%	$-196.4K	$-71.0K	$-0.02	—
Q3 2024	$0.00	NaN%	$-61.3K	$-61.3K	$-0.02	—
Q2 2024	$0.00	NaN%	$-843.00	$-843.00	$-0.00	—
Q1 2024	$0.00	NaN%	$-843.00	$-843.00	$-0.00	—
Q4 2023	$0.00	NaN%	$-483.8K	$-483.8K	$-0.12	—
FY 2023	$0.00	NaN%	$-485.6K	$-485.6K	$-0.12	—